The costs of intensive care

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 6, Issue 4, 2006, Pages 160-163

  Seidel, J ^a   Whiting, P C ^a   Edbrooke, D L ^b  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748060866     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkl030     Document Type: Article

References (9)

1. Gyldmark M. A review of cost studies of intensive care units: Problems with the cost concept. Crit Care Med 1995; 23: 964-72
2. Dean J, Edbrooke D, Corcoran M. The critical care national cost block programme: Implementing a standard costing method on a national scale. Care Crit III 2002; 18: 1-3
3. Edbrooke DL, Hibbert CL, Kingsley JM, Smith S, Bright NM, Quinn JM. The patient-related cost of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med 1999; 27: 1760-7
4. Noseworthy TW, Konopad E, Shustack A, Johnson R, Grace M, Eng P. Cost accounting of adult intensive care: Methods and human and capital inputs. Crit Care Med 1996; 24: 1168-1173
5. Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H. The development of a method for comparative costing of individual intensive care units. Anaesthesia 1999; 54: 110-20
6. Negrini D, Sheppard L, Mills G, Jacobs P, Rapoport J, Bourne RS, Guidet B, Csomos A, Prien T, Anderson G, Edbrooke DL. International Programme for resource use in Critical care (IPOC) - a methodology and initial results of cost and provision in four European countries. Acta Anaesthesiol Scand 2006; 50: 72-9
7. Bernard GR, Vincent J-L, Lattere PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
8. Manns J, Lee H, Doig C, Johnson D, Donaldson C. An economic evaluation of Activated Protein C treatment for sepsis. N Engl J Med 2002; 347: 993-1000
9. Angus D, Lind-Zwirble W, Clermont G, Ball D, Basson B, Ely W, Laterre PF, Vincent JL, Bernard G, Van Hout B. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 2003; 31: 1-11